Pramlintide, the first generation (1990s) In the 1990s, the pharmaceutical company Amylin Pharmaceuticals developed Pramlintide , a modified amylin with three proline substitutions at positions 25, 28 and 29
Peptides Research Verified
Originally developed for type 2 diabetes, semaglutide has shown exceptional promise in promoting sustainable weight loss
Intended Use Intended Use For laboratory research use only
Research in mice lacking HO-1 has revealed the overall function of HO-1 in restoring functional macrophages, maintaining iron balance within tissues, and increasing tolerance to oxidative stress conditions [98,99,100]
Yuen Yee Polly TUNG Good quality products